Open Studies
This study will include both individuals who have been provided with a diagnosis of bipolar disorder at some point in their lifetime and individuals who are spouses or partners of an individual with bipolar disorder.
Contact: See Link
Virtual Environments & BD + Partners
This study will include both individuals who have been provided with a diagnosis of bipolar disorder at some point in their lifetime and individuals who are spouses or partners of an individual with bipolar disorder.
Contact: See Link
Currently recruiting adults, ages 18-65 who are suffering from bipolar disorder.
Contact: 713-486-2627
Greater Houston Area Bipolar Registry
This an initiative aimed at providing a detailed clinical and neurobiological longitudinal evaluation of children with bipolar disorder and offspring of parents with bipolar disorder.
Contact: 713-486-2627
This study assesses the safety and tolerability of Candesartan as an adjunctive treatment of bipolar depression. All patients will receive the study drug for four weeks and a placebo for four weeks. Neither the patients nor the study team will know if the patient received the study drug or the placebo first.
Contact: 713-486-2627
Magnetic Seizure Therapy in Bipolar Depression
Currently recruiting adults, ages 22 to 85. Patients must be currently receiving treatment for bipolar disorder and be experiencing symptoms of depression.
Contact: 713-486-2627
Stem Cells for Treatment Resistant Bipolar Depression
This study aims to examine the safety and efficacy of Allogenic Mesenchymal Stem Cells (MSCs) as an adjunctive treatment of treatment resistant bipolar depression. Patients will be assigned into a treatment or a placebo group.
Contact: 713-486-2627
The UTHealth Center of Excellence on Mood Disorders at the Faillace Department of Psychiatry and Behavioral Sciences is collaborating with LivaNova, a global medical technology company, to start a new clinical trial – the “RECOVER study” – to help treat depression.
Contact: 713-486-2627